Related by context. All words. (Click for frequent words.) 72 bone marrow fibrosis 64 Erythropoietic therapies may 63 hemorrhagic complications 61 nonhematologic adverse reactions 61 strong CYP#A# inducers 60 upper gastrointestinal bleeding 60 Serious adverse reactions 60 ARCALYST ® 59 Lactic acidosis 59 severe hypersensitivity reactions 59 VIIBRYD 59 myopathy rhabdomyolysis 59 nephrotoxicity 58 somnolence dizziness 58 delayed CINV 58 thromboembolism 58 systemic hypotension 58 electrolyte abnormalities 58 primidone 58 renal toxicity 58 torsade de pointes 58 intracranial hemorrhage ICH 58 dermatologic reactions 58 Entereg R 58 recurrent ischemia 58 MULTAQ 58 Infusion Reactions Severe 58 orthostatic hypotension 58 cytopenias 58 TEAEs 58 fluid overload 58 benazepril 57 metabolic acidosis 57 coadministration 57 TNF antagonist 57 β blocker 57 hyperprolactinemia 57 prolonged QT interval 57 Torsades de Pointes 57 apneic episodes 57 Fibrillex TM 57 headache nausea diarrhea 57 ATACAND 57 metformin accumulation 57 hepatotoxicity 57 constipation nausea 57 cobiprostone 57 angioneurotic edema 57 corticosteroid therapy 57 ACTOplus met XR 57 bone marrow suppression 57 heparin induced thrombocytopenia 57 tumor lysis syndrome 57 antiplatelet medications 57 Hypotension 57 ischemic complications 57 thromboembolic events 57 QT interval prolongation 57 nasopharyngitis headache 57 FluCAM arm 57 thrombotic events 57 postoperative AF 57 Severe hypersensitivity reactions 56 dopaminergic therapy 56 preterm newborns 56 mycophenolic acid 56 diarrhea vomiting nausea 56 BANZEL 56 Rasilez Tekturna 56 neutropenia thrombocytopenia 56 hypercholesterolaemia 56 symptomatic hypotension 56 REMICADE ® 56 gastrointestinal perforation 56 riociguat 56 electrolyte disturbances 56 extrapyramidal symptoms 56 macrovascular 56 unresectable HCC 56 AVANDIA 56 mucocutaneous reactions 56 refractory gout 56 LYSTEDA 56 venous thromboembolic events 56 Neutropenia 56 Exacerbations 56 treat dysmenorrhea 56 headache abdominal pain 56 EDARBI 56 CIMZIA TM certolizumab pegol 56 postoperative morbidity 56 KETEK 56 neutropenia dehydration dyspnea 56 nephrotoxic drugs 56 hypomagnesemia 56 Hypocalcemia 56 postsurgical pain 56 peginterferon alfa 56 thrombotic complications 56 dizziness somnolence 56 EXJADE 56 alpha interferons 56 hypercalcemia 56 EFFEXOR XR 56 Aprotinin 56 QTc interval 55 concomitant medications 55 oxycodone CR 55 diarrhea headache nausea 55 tapentadol ER 55 postoperative ileus POI 55 pancytopenia 55 APTIVUS r 55 severe exacerbations 55 acromegalic patients 55 chronic idiopathic thrombocytopenic purpura 55 hyperkalemia 55 DETROL LA 55 inhaled glucocorticoids 55 receiving XGEVA 55 COPD exacerbations 55 hepatic failure 55 NUCYNTA ™ 55 APTIVUS ritonavir 55 torsades de pointes 55 venous thromboembolic disease 55 Hepatotoxicity 55 ALT flares 55 discontinuations due 55 QTc intervals 55 painful menstruation 55 Known hypersensitivity 55 Heavy snorers 55 anemia neutropenia 55 incidence ≥ 55 systemic immunosuppressive drugs 55 vasogenic edema 55 diarrhea dyspepsia 55 TELINTRA 55 tardive dyskinesia TD 55 TMP SMX 55 Sleep disturbances 55 elevated IOP 55 hematologic toxicity 54 endometrial hyperplasia 54 Thrombocytopenia 54 torsemide ER 54 interferon gamma 1b 54 fatal anaphylactic 54 hypoglycemic events 54 cerebral vasospasm 54 receiving VELCADE 54 lactic acidosis 54 QTc prolongation 54 BEXXAR Therapeutic Regimen 54 pulmonary exacerbations 54 cerebral ischemia 54 myalgia arthralgia 54 Oral corticosteroids 54 G6PD deficiency 54 anemia thrombocytopenia 54 Coadministration 54 sotalol 54 Dose adjustments 54 dosing frequency 54 opioid induced 54 elotuzumab 54 retrograde ejaculation 54 hypocalcemia 54 HMG CoA reductase inhibitors 54 zileuton IV 54 anaphylactoid reactions 54 Tasigna prolongs 54 lomitapide 54 gastrointestinal disturbances 54 extrapyramidal symptoms EPS 54 TOVIAZ 54 erythema redness 54 antioxidant supplementation 54 thromboembolic 54 elevated bilirubin 54 Discontinuations 54 oxcarbazepine 54 recurrent venous thromboembolism 54 peripheral neuropathy CIPN 54 ischemic cardiovascular 54 oral antidiabetic drugs 54 Hepatic Impairment 53 daytime drowsiness 53 frequent awakenings 53 pyrexia mucositis sepsis febrile 53 bleeding ulceration 53 flecainide 53 symptomatic hyponatremia 53 nausea constipation 53 unstable angina pectoris 53 Oral mucositis 53 lichen planus 53 vasodilatation 53 pulls Darvon painkiller 53 venlafaxine ER 53 myelosuppression 53 nocturnal hypoglycaemia 53 BYSTOLIC 53 hepatic insufficiency 53 bezafibrate 53 SUSTENNA TM 53 HeFH 53 urinary retention 53 intraoperative complications 53 thrombocytopenia neutropenia 53 Vitamin D insufficiency 53 hypoglycaemic episodes 53 nausea dizziness vomiting 53 inhaled budesonide 53 Primary endpoints 53 nausea vomiting headache dizziness 53 isoproterenol 53 analgesic medications 53 angioedema 53 uridine triacetate 53 esophageal perforation 53 atherothrombotic 53 loop diuretics 53 Thrombotic events 53 Tardive dyskinesia 53 headache nasopharyngitis 53 Serious Adverse Events 53 Renal impairment 53 potassium sparing diuretics 53 cardiac repolarization 53 anaphylactic reactions bronchospasm 53 coronary revascularization procedures 53 syncope fainting 53 macrovascular complications 53 arterial thromboembolic events 53 intracerebral hemorrhage 53 hyponatraemia 53 Severe allergic reactions 53 SILENOR TM 53 Prosaptide 53 autoimmune reactions 53 dizziness constipation 53 cardiac conduction 53 antithrombotic agent 53 transaminase elevations 53 severe asthma exacerbations 53 Hematologic 53 parasitemia 53 chemotherapy induced neutropenia 53 oral NSAIDs 53 untreated OSA 53 adrenal suppression 53 comorbid psychiatric 53 rhythm disturbances 53 chlorpheniramine 53 Myfortic 53 hemorrhagic cystitis 53 CYP #A# 53 salmeterol HFA MDI 53 virologic breakthrough 53 phototoxicity 53 thrombophlebitis 53 swelling edema 52 gemifloxacin 52 discontinuations 52 vasomotor symptoms 52 pulmonary infiltrates 52 neuropsychiatric symptoms 52 clazosentan 52 REBETOL therapy 52 neonatal morbidity 52 TRISENOX 52 lumiracoxib 52 symptomatic NOH 52 severe hepatic dysfunction 52 mycophenolate mofetil 52 neutropenia anemia 52 ALTACE 52 oxymorphone ER 52 gastrointestinal ulcers 52 antidiabetic medications 52 menadione 52 constipating effects 52 Gastroesophageal Reflux 52 ursodeoxycholic acid 52 containing abacavir 52 Rituxan infusion 52 postoperative infections 52 Dyspepsia Tachycardia Myalgia etc. 52 Estrogen deficiency 52 potentially hepatotoxic 52 hypopituitarism 52 fetal malformations 52 cerebrovascular events 52 Anaphylactic reactions 52 digoxin toxicity 52 renal insufficiency 52 parkinsonian symptoms 52 HPA axis suppression 52 peripheral sensory neuropathy 52 neurologic dysfunction 52 cardiac valvulopathy 52 nausea vomiting dizziness 52 severe hypoglycemia 52 impaired renal 52 febrile neutropenia 52 chronic pancreatitis CP 52 Aggrastat ® tirofiban hydrochloride 52 Triptan 52 macrovascular disease 52 aspirin NSAIDs 52 Ticagrelor 52 Daytrana TM 52 desvenlafaxine succinate 52 ICD shocks 52 ocular adverse 52 oral levofloxacin 52 related hematological toxicity 52 β blockers 52 CYP#A# inhibitor 52 infusion reactions 52 Syndrome RLS 52 tiagabine 52 cerebrovascular accidents 52 liver transaminases 52 gout flare 52 dizziness sleepiness 52 Bioaccelerate compounds under 52 leucopenia 52 ARCOXIA 52 decompensated heart failure 52 intravenous bisphosphonates 52 gastrointestinal perforations 52 linaclotide treated 52 nonvertebral fracture 52 probiotic supplementation 52 simvastatin ezetimibe 52 spontaneous preterm delivery 52 nonischemic 52 GI bleeds 52 Adverse reactions 52 non selective NSAIDs 52 overactive bladder symptoms 52 lymphopenia 52 Hypersensitivity reactions 52 HF hospitalization 52 HIV HCV coinfected 52 inotropes 52 amifostine 51 danazol 51 ACIPHEX 51 genotypic resistance 51 hepatic toxicity 51 H2 antagonists 51 embolic stroke 51 H2 blocker 51 QT prolongation 51 cardiovascular ischemic 51 thrombo embolic 51 dermatologic toxicities 51 postoperative bleeding 51 CV thrombotic 51 dysrhythmias 51 somnolence sedation 51 venous thromboembolic 51 Calcium intake 51 neutropenic patients 51 light headedness dizziness 51 neurocognitive deficits 51 del 5q MDS 51 INVEGA ® 51 gastrointestinal toxicities 51 diarrhea nausea vomiting 51 Drospirenone 51 mania hypomania 51 amenorrhea 51 Telithromycin 51 Selective Serotonin Reuptake Inhibitor 51 Acetaminophen Tylenol 51 dysmenorrhoea 51 haemorrhagic stroke 51 Acute Radiation Syndrome ARS 51 induced hypoglycemia 51 symptomatic paroxysmal AF 51 myocardial infarction stroke 51 Premature menopause 51 fatal myocardial infarction 51 serotonin syndrome 51 efficacy tolerability 51 inflammatory biomarkers 51 experienced hypomagnesemia 51 leukopenia 51 Ramoplanin 51 peripheral edema 51 breast tenderness bloating 51 lacosamide 51 silent ischemia 51 indiplon capsules 51 lipid lowering therapies 51 immunotoxicity 51 SRBD 51 GSK# [001] 51 pharmacokinetic interactions 51 Adentri 51 oral antidiabetes 51 vaginal yeast infections 51 RLS symptoms 51 hypertension systolic blood 51 Tylenol acetaminophen 51 heterozygous FH 51 acetaminophen paracetamol 51 testicular tumors 51 Telintra 51 EMEND 51 diabetic neuropathic pain 51 liver dysfunction 51 statistically significant superiority 51 haematologic 51 efaproxiral 51 unmeasured confounders 51 Treatment discontinuations due 51 teratogenic effects 51 sinus tachycardia 51 didanosine associated 51 lipid parameters 51 morbidity mortality 51 mucosal inflammation 51 irregular menstruation 51 thrombosis blood clots 50 NUEDEXTA 50 disordered breathing 50 reactogenicity 50 gonococcal 50 elevated ALT 50 malignancy HCM 50 balsalazide 50 anticholinergic agents 50 KIF6 carriers 50 hallucinations dyskinesia 50 fluoxetine Prozac 50 recurrent DVT 50 RAPTIVA 50 anticoagulant warfarin 50 azoospermia 50 serious cardiovascular thrombotic 50 TAXOTERE ® 50 pericardial effusion 50 neurologic complications 50 panitumumab Vectibix 50 optic neuropathy NAION 50 TNF blocker therapy 50 hematologic abnormalities 50 Peripheral edema 50 capillary leak 50 prednisone prednisolone 50 VIOXX Lawsuits 50 recurrent VTE 50 hypersensitivity allergic reactions 50 thrombotic thrombocytopenic purpura TTP 50 liver decompensation 50 Critical limb ischemia 50 parecoxib 50 antiplatelet therapies 50 Paxil paroxetine 50 risksassociated 50 oral mTOR inhibitor 50 headache arthralgia 50 ovarian hyperstimulation syndrome OHSS 50 fibrate drugs 50 limiting toxicity 50 TOPAMAX ® 50 neutropenic fever 50 erythropoietic 50 tibolone 50 1mg dose 50 Secondary endpoints included 50 adverse cytogenetics 50 NUCYNTA TM 50 levodopa induced 50 KRAS mutant tumors 50 ventricular fibrillation VF 50 events TEAEs 50 antiarrhythmic drugs 50 ß blockers 50 CIPN 50 bovine thrombin 50 hypersensitivity reaction 50 severe hypoglycaemia 50 neutropaenia 50 ocular infections 50 headache vomiting 50 NAbs 50 Progressive Multifocal Leukoencephalopathy PML 50 recurrent ischemic 50 hemoptysis 50 LPM TM 50 pharmacokinetic interaction 50 fulminant hepatitis 50 radiation dermatitis 50 Quetiapine 50 periprocedural 50 thrombocytopenia anemia 50 acitretin 50 INTEGRILIN ® 50 atopic disease 50 nephrotoxic 50 neurodevelopmental outcome 50 arterial thromboembolic 50 Peptic ulcers 50 CYP#A# inhibitors 50 platelet dysfunction 49 hyperbilirubinemia 49 primary Restless Legs 49 Diabetic Mellitus 49 nonfatal MI 49 plasma pharmacokinetics 49 Market Disruption 49 severe hepatic insufficiency 49 behavioral disturbances 49 Pruvel 49 pharmacodynamic parameters 49 acute phosphate nephropathy 49 tegaserod 49 anovulation 49 TDF FTC 49 ergotamine 49 neurological sequelae 49 Paliperidone 49 primary axillary hyperhidrosis 49 immunosuppressive agents 49 hypotensive 49 Carotid endarterectomy 49 Dextofisopam 49 Genetic predisposition 49 indigestion heartburn 49 mitochondrial toxicity 49 hypoglycemic episodes 49 PDE 5i 49 containing LABAs 49 prolactin levels 49 aplindore 49 inhaled bronchodilators 49 Magnesium deficiency 49 Skin rashes 49 thorough QT 49 DSL.net s 49 swelling stiffness 49 INVEGA ™ 49 RISPERDAL ® 49 Withdrawal symptoms 49 concomitant medication 49 dexrazoxane 49 infants Sundlof 49 Auxilium anticipates 49 painful menstrual periods 49 achieving PASI 49 nasopharyngitis 49 Iron deficiency anemia 49 Irinotecan Hydrochloride Injection 49 nonaspirin 49 IgE mediated 49 RAS blockers 49 hepatic dysfunction 49 orlistat Xenical 49 mitral insufficiency 49 metabolic disturbances 49 paracetamol aspirin 49 INTEGRILIN 49 Avandia Actos 49 MAO inhibitors 49 neurologic sequelae 49 NNT = 49 containing drospirenone 49 AGGRASTAT ® tirofiban hydrochloride 49 Severe infusion 49 Edarbi 49 gastrointestinal absorption 49 impaired cognition 49 headache nausea fatigue 49 AML MDS 49 progestogens 49 NUCYNTA ® 49 Bextra valdecoxib 49 paresthesias 49 predisposing factor 49 suboptimal adherence 49 antiepileptics 49 NUCYNTA R 49 vernakalant oral 49 hepatitis B infection 49 nausea diarrhea 49 oral prednisolone 49 SSRI antidepressant 49 gait disturbance 49 varicella infection 49 syncopal 49 maximal doses 49 PLAVIX ® 49 poststroke depression 49 Postmarketing 49 Testosterone deficiency 49 gastrointestinal GI bleeding 49 cardiovascular thrombotic 49 severe hypoglycemic 49 Secondary endpoints include 49 cholecystitis 49 omecamtiv mecarbil 49 neurocognitive outcomes 49 premenstrual syndrome PMS 49 gabapentin Neurontin 49 thiazide 49 lenalidomide dexamethasone 49 antidepressants fluoxetine 49 tonsillar hypertrophy 49 MEVACOR 49 hematologic adverse 48 pamidronate 48 immunological responses 48 hematological toxicity 48 strong CYP#A# inhibitors 48 ADCS CGIC 48 COPEGUS therapy 48 events thrombocytopenia neutropenia 48 anticoagulant medications 48 VT VF 48 Stent thrombosis 48 paroxetine sertraline 48 intracerebral haemorrhage 48 sedating antihistamines 48 dose limiting toxicities 48 bladder contractions 48 anemia leukopenia 48 pathologic fractures 48 depression suicidality 48 activate AMPK 48 venlafaxine XR 48 cSSSIs 48 cortical excitability 48 gastrointestinal bleeds 48 alkalosis 48 androgen deprivation 48 motesanib 48 Eloxatin ® 48 polytherapy 48 insomnia somnolence 48 antidiabetic drugs 48 anticonvulsant drugs 48 Dermatologic toxicities 48 myelosuppressive chemotherapy 48 thrombocytopenia 48 AGGRASTAT R tirofiban hydrochloride 48 monoamine oxidase inhibitors 48 Glycopyrrolate 48 external genital lesions 48 Secondary endpoints 48 akathisia 48 coinfected patients 48 varenicline Chantix 48 impair fertility 48 drowsiness nausea 48 irregular menses 48 dyslipidemias 48 hormone receptor negative 48 paliperidone ER 48 NMDA antagonists 48 antiseizure medications 48 selegiline 48 Digoxin toxicity 48 systemic toxicity 48 Tß4 48 relieve constipation 48 conjugated estrogen 48 photosensitivity 48 oral olanzapine 48 vasodilatory 48 Liver toxicity 48 pulmonary exacerbation 48 dose corticosteroids 48 nausea vomiting constipation 48 Vaginal dryness 48 vascular reactivity 48 cutaneous lupus 48 stent thrombosis blood clots 48 endogenous hormones 48 opioid mediated 48 cartilage degeneration 48 Toxicities 48 depressive symptomatology 47 pralidoxime 47 Kidney toxicity nephrotoxicity 47 Retrograde ejaculation 47 nasal symptoms 47 desipramine 47 Menopausal symptoms 47 Airvana anticipates 47 GI perforation 47 intermittent hypoxia 47 liver toxicity 47 antidepressant efficacy 47 reflux symptoms 47 laboratory abnormalities 47 multivariate adjustment 47 etomidate 47 GEMZAR 47 leukotriene receptor antagonists 47 guinea pigs lubiprostone 47 hematologic toxicities 47 bloating constipation 47 topical NSAIDs 47 neuropsychiatric events 47 concomitant cardiac 47 mu opioid agonists 47 orofacial clefts 47 vomiting abdominal pain 47 Reye syndrome rare 47 N acetyl cysteine 47 Low Doses 47 PDE4 inhibitors 47 capillary leakage 47 events AEs 47 vascular insufficiency 47 microvascular complications 47 extrapyramidal side 47 inhaled iloprost 47 causes myocardial ischemic 47 pentoxifylline 47 bacteriuria 47 unknown etiology 47 Gastrointestinal GI 47 reproductive abnormalities 47 macroburst Ciemnecki 47 ischemic cerebrovascular 47 Suicidal ideation 47 paliperidone 47 acid reflux heartburn 47 obstetric complications 47 treatment emergent adverse 47 SSRI SNRI 47 maternal morbidity 47 potassium supplementation 47 anticholinergic effects 47 CYP#D# inhibitor 47 causative pathogen 47 unmeasured factors 47 ACEIs 47 unfavorable cytogenetics 47 histrelin manufacturing marketing 47 enteric coatings 47 interstitial pneumonia 47 Febrile neutropenia 47 gastric irritation 47 neutropenic sepsis 47 cardiac toxicity 47 Anturol 47 NORVIR 47 impaired insulin secretion 47 EEG abnormalities 47 androgen suppression 47 antiinflammatory drugs 47 ovarian hormones 47 elevated prolactin 47 Adverse effects 47 phosphodiesterase type 5 47 overlapping toxicities 47 urate lowering 47 CYP#D# inhibitors 47 Peripheral neuropathies 47 MAO inhibitor 47 SILENOR ™ 47 dizziness drowsiness 47 ddI 47 opioid naïve 47 mucositis 47 Discontinuation 47 postprocedure 47 PMS symptoms 47 hypersensitivity reactions 47 dyspnoea 47 photosensitivity rash 47 statin medications 47 menstrual abnormalities 47 lowering homocysteine 47 abrupt discontinuation 47 RISPERDAL 47 noncardiovascular mortality 47 Vertebral fractures 47 immunocompromised individuals 47 elevated plasma concentrations 47 anginal 47 topical corticosteroids 46 ocular toxicity 46 chromium picolinate supplementation 46 resuscitated cardiac arrest 46 delayed gastric emptying 46 neurologic outcomes 46 neuropsychological impairments 46 Kaplan Meier estimates 46 KAPVAY ™ 46 sodium valproate 46 cSSSI 46 naprosyn 46 NEUMUNE 46 congenital malformations 46 Immtech clinical trials 46 neuroleptic malignant syndrome 46 beta carotene supplementation 46 postmarketing surveillance 46 symptom flare ups 46 prolactin elevation 46 SREs 46 nausea diarrhea vomiting 46 Adverse Effects 46 Anticholinergic 46 O PPDS 46 Hematologic toxicity 46 opioid agonists 46 concomitant AEDs 46 hepatotoxic 46 Reglan metoclopramide 46 PPAR gamma agonists 46 Acneform rash occurred 46 clinically meaningful differences 46 carotid atherosclerosis 46 Acute pancreatitis 46 Chronic hepatitis C 46 menstrual cramping 46 CVD mortality 46 glitazone class 46 nonhealing wounds 46 statins cholesterol lowering 46 atypical antipsychotic medications 46 tolterodine 46 neuropsychiatric adverse 46 fatigue asthenia 46 headaches stomach aches 46 iodine intake 46 indomethacin 46 events SAEs 46 aprepitant 46 stroke myocardial infarction 46 hematological adverse 46 coronary artery atherosclerosis 46 Zavesca ® 46 hematological toxicities 46 headache flushing 46 systemic absorption 46 ergot alkaloids 46 acid suppressive therapy 46 cerebral ischemic 46 antiepileptic drugs 46 symptom exacerbation 46 Osteoporotic fractures 46 Antioxidant supplements 46 serious Interstitial Lung 46 antitumor effect 46 GlaxoSmithKline Plc Paxil 46 improving insulin sensitivity 46 asthma exacerbation 46 immunomodulatory effects 46 sedating medications 46 anaphylactic reactions 46 cranial irradiation 46 nonfatal stroke 46 statins fibrates 46 triglyceride lowering 46 abruption 46 untreated hypothyroidism 46 L lysine 46 adverse perinatal 46 serologically active patients 46 acneform rash 46 brompheniramine 46 bronchodilatory 46 ROZEREM TM 46 dietary deficiency 46 anaphylactoid 46 Serious ocular 46 antenatal depression 46 GnRH antagonists 46 inhaled nitric oxide 46 Pfizer Aricept 46 opiate analgesics 46 androgen depletion therapy 46 mycophenolate 46 immunomodulation 45 frequent bowel movements 45 rhythm abnormalities 45 otherfactors 45 analgesic effects 45 cardiotoxic 45 thienopyridine 45 prolonged cytopenias 45 Toric ICL 45 improves insulin sensitivity 45 adiponectin levels 45 plasma lipid 45 thyroid hormone levels 45 prostaglandin E1 45 transient insomnia 45 sensory neuropathy 45 agitation irritability 45 hypoglycaemia 45 hormonal disturbances 45 digestive disturbances 45 hormonal deficiencies 45 jaw osteonecrosis 45 antitumor effects 45 ischemic cardiac 45 endogenous opioid 45 EGFRIs 45 inhaled anticholinergics 45 SPARLON 45 Subgroup analyzes 45 inhaled tobramycin 45 newer atypical antipsychotics 45 Tekturna ® 45 strategic pharmacovigilance WebVDME 45 NNRTI resistance 45 acute ischemic 45 PDE 5i medications 45 immune dysregulation 45 moderately emetogenic 45 inhibits platelet aggregation 45 apnea hypopnea 45 events ADEs 45 nasal irritation 45 hypoglycemia 45 monoamine 45 neutropenia febrile neutropenia 45 dietary calcium intake 45 acid suppressive drugs 45 Pristiq desvenlafaxine 45 limb spasticity 45 event reporting Clintrace 45 receptor inhibitor 45 lethargy irritability 45 uncertainties materialize Shire 45 spinal cord compression 45 serum homocysteine 45 prothrombotic 45 induce regression 45 Sepracor anticipates 45 Bcr Abl mutations 45 #mg dose [003] 45 divalproex 45 hypokalaemia 45 metabolic dysfunctions 45 drugs NSAIDS 45 contingent guaranties 45 atherosclerotic progression 45 immune suppression 45 naronapride 45 superficial edema 45 hypoglycaemic 45 thrombotic 45 PegIFN RBV 45 neurodevelopmental outcomes 45 Elecsys Corporation SEC 45 strategic pharmacovigilance Empirica 45 anticholinergic drugs 45 CETP inhibition 45 chlamydial 45 angiogenic therapy 45 Cynosure anticipates 45 preterm neonates 45 dizziness heart palpitations 45 risks anduncertainties 45 threatening ventricular arrhythmias 45 asthma flare ups 45 ALRI 45 inhibit platelet function 45 nasal polyposis 44 xxv 44 acute coronary 44 vitamin B# supplements 44 mGluR4 activation 44 Discontinuations due 44 male hormone androgen 44 severe hypoglycemic episodes 44 DLTs 44 tissue necrosis 44 atherosclerotic cardiovascular 44 ultra rapid metabolizers 44 atypical femur fractures 44 selective NSAIDs 44 Ambrilia views 44 pulmonary toxicity 44 subclinical cardiovascular disease 44 itraconazole 44 neutropenia 44 unmeasured confounding 44 TYSABRI treated 44 prophylactic anticoagulation 44 PR interval prolongation 44 painkiller acetaminophen 44 vaccinees 44 DHEA supplementation 44 nonfatal cardiovascular